• 2008

Company Description

Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.

Albireo is an independent Swedish biotechnology company, which brings unique translational approaches to develop drugs that fulfil unmet medical needs in the gastrointestinal (GI) area. The team has a broad experience in drug development, primarily in the GI area and has an extensive network in the international scientific and clinical communities.